Seeking Alpha

Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) announce their experimental Zaltrap drug...

Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) announce their experimental Zaltrap drug didn't meet targets in a late-stage Phase III trial. Despite the miss, the firms say the FDA granted a priority review to examine the proposed treatment for colon cancer.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector